SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040075
Filing Date
2019-11-05
Accepted
2019-11-05 08:28:52
Documents
84
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-10q_20190930.htm 10-Q 2382014
2 EX-10.1 xoma-ex101_227.htm EX-10.1 368203
3 EX-10.2 xoma-ex102_320.htm EX-10.2 77746
4 EX-31.1 xoma-ex311_9.htm EX-31.1 15921
5 EX-31.2 xoma-ex312_6.htm EX-31.2 15926
6 EX-32.1 xoma-ex321_8.htm EX-32.1 7253
  Complete submission text file 0001564590-19-040075.txt   10236369

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT xoma-20190930.xml EX-101.INS 1937473
8 XBRL TAXONOMY EXTENSION SCHEMA xoma-20190930.xsd EX-101.SCH 110963
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xoma-20190930_cal.xml EX-101.CAL 65485
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20190930_def.xml EX-101.DEF 354090
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20190930_lab.xml EX-101.LAB 723782
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20190930_pre.xml EX-101.PRE 554139
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14710 | Film No.: 191191857
SIC: 2834 Pharmaceutical Preparations